Annotation Detail for ITGAX
Basic Information Top
Gene Symbol: | ITGAX ( CD11C,SLEB6 ) |
---|---|
Gene Full Name: | integrin, alpha X (complement component 3 receptor 4 subunit) |
Band: | 16p11.2 |
Quick Links | Entrez ID:3687; OMIM: 151510; Uniprot ID:ITAX_HUMAN; ENSEMBL ID: ENSG00000140678; HGNC ID: 6152 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C111855 | 6-formylindolo(3,2-b)carbazole | 6-formylindolo(3,2-b)carbazole results in decreased expression of ITGAX protein | decreases expression | 20350561 |
D000082 | Acetaminophen | Acetaminophen affects the expression of ITGAX mRNA | affects expression | 17562736 |
C103303 | alitretinoin | Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGAX protein] | increases expression|increases reaction | 15964820 |
C103303 | alitretinoin | Vitamin D promotes the reaction [alitretinoin results in increased expression of ITGAX protein] | increases expression|increases reaction | 15964820 |
C015001 | arsenite | arsenite results in decreased expression of ITGAX mRNA | decreases expression | 18191166 |
D002927 | Cimetidine | Cimetidine results in decreased expression of ITGAX protein | decreases expression | 11556524 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGAX protein] | increases expression|increases reaction | 15964820 |
C051890 | irinotecan | irinotecan metabolite results in increased expression of ITGAX mRNA | increases expression | 15956246 |
C051890 | irinotecan | irinotecan results in increased expression of ITGAX mRNA | increases expression | 15956246 |
C043062 | N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine | N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine results in decreased expression of ITGAX protein | decreases expression | 11556524 11306145 |
D010126 | Ozone | Ozone results in increased expression of ITGAX protein | increases expression | 15036748 |
D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased expression of ITGAX mRNA | increases expression | 16251409 |
D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ITGAX protein] | affects reaction|decreases expression | 20350561 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of ITGAX protein | decreases expression | 20350561 |
D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGAX mRNA | affects cotreatment|affects expression | 16979875 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of ITGAX mRNA | decreases expression | 18087596 |
D014212 | Tretinoin | Tretinoin results in increased expression of ITGAX mRNA | increases expression | 15770638 15988048 |
D014212 | Tretinoin | Tretinoin results in increased expression of ITGAX protein | increases expression | 16764927 17361223 15770638 |
D014311 | Triprolidine | Triprolidine results in decreased expression of ITGAX protein | decreases expression | 11556524 |
D014807 | Vitamin D | Vitamin D promotes the reaction [alitretinoin results in increased expression of ITGAX protein] | increases expression|increases reaction | 15964820 |
D002762 | Cholecalciferol | [Cholecalciferol co-treated with TGFB1 protein] results in increased expression of ITGAX mRNA | affects cotreatment|increases expression | 15988048 |
D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGAX mRNA | affects cotreatment|affects expression | 16979875 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.81 | 15322242 11752688 14514962 | |
MESH:D000169 | Acrodermatitis | Zinc | 5.37 | 16889938 17190629 17202136 | |
MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Tobacco Smoke Pollution | 5.50 | 15814487 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 3.34 | 16835633 | |
MESH:D000505 | Alopecia | Tretinoin | 3.58 | 15955085 | |
MESH:D000544 | Alzheimer Disease | Ozone | 4.42 | 15513908 | |
MESH:D000544 | Alzheimer Disease | Zinc | 4.42 | 16580781 16325427 16410023 17119284 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.91 | 11748828 | |
MESH:D000755 | Anemia, Sickle Cell | Zinc | 4.86 | 16916123 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.81 | 10982225 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 3.05 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Ozone | 7.47 | 15570426 | |
MESH:D001172 | Arthritis, Rheumatoid | Tobacco Smoke Pollution | 7.47 | 19898480 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 7.47 | 16292516 | |
MESH:D001195 | Asbestosis | Asbestos, Serpentine | 5.63 | 10751356 | |
MESH:D001249 | Asthma | Ozone | 7.91 | 16373670 17854713 | |
MESH:D001249 | Asthma | Tretinoin | 7.91 | 16456186 | |
MESH:D001249 | Asthma | Zinc | 7.91 | 17085522 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 1.42 | 18445737 | |
MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 4.99 | 16142846 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 4.36 | 16935849 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 8.80 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 8.80 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.76 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.73 | 15746008 | |
MESH:D001930 | Brain Injuries | Zinc | 4.65 | 17109824 | |
MESH:D001943 | Breast Neoplasms | alitretinoin | 2.08 | 16344269 | |
MESH:D001943 | Breast Neoplasms | N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine | 2.08 | 18986763 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 2.08 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 2.08 | 16166294 16443354 16873071 | |
MESH:D016535 | Bronchial Hyperreactivity | Ozone | 3.64 | 14754758 15516495 17626835 18417511 19059883 18315731 16777450 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.55 | 16813970 | |
MESH:D002100 | Cachexia | Ozone | 4.70 | 16183385 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.76 | 16835633 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 5.13 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 2.84 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 2.84 | 1917145 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Tobacco Smoke Pollution | 3.41 | 11212258 | |
MESH:D002294 | Carcinoma, Squamous Cell | N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine | 14.28 | 18986763 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 14.28 | 18922899 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tobacco Smoke Pollution | 14.28 | 11212258 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 14.28 | 16051514 16096774 | |
MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 14.28 | 16543248 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.34 | 16120746 18670907 18850075 | |
MESH:D002318 | Cardiovascular Diseases | Zinc | 3.63 | 16936243 | |
MESH:D002386 | Cataract | Acetaminophen | 7.14 | 10977129 | |
MESH:D002386 | Cataract | Tretinoin | 7.14 | 17460283 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.55 | 16129372 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 3.12 | 16835633 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 5.13 | 16461808 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.70 | 12621046 16354765 15668235 15340226 8697196 | |
MESH:D002972 | Cleft Palate | Tretinoin | 5.70 | 9407595 | |
MESH:D003092 | Colitis | Tretinoin | 3.66 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | arsenite | 4.07 | 15037631 | |
MESH:D003110 | Colonic Neoplasms | irinotecan | 4.07 | 17725105 17287894 | |
MESH:D015179 | Colorectal Neoplasms | irinotecan | 2.36 | 17454858 18259882 16303861 17159606 15273666 16391804 18509181 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 3.02 | 17141729 14669216 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 3.81 | 15322242 10048152 20055451 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 3.81 | 14991402 16925845 9125849 10589399 9142499 17551590 8800419 9664655 9211117 9224671 | |
MESH:D019465 | Craniofacial Abnormalities | Zinc | 3.81 | 19302082 | |
MESH:D003920 | Diabetes Mellitus | Zinc | 4.16 | 16479319 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 1.66 | 17107852 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 3.51 | 19739265 19923254 17522070 16485898 11461765 19420014 15968718 10774834 14725611 12594235 11287661 14986274 16227642 12153990 16781746 11529661 19085960 12540782 19416960 2444490 11421492 11743745 12958197 11739529 16177239 12392966 18071297 19164858 16109766 15619225 17906064 16393943 16081117 19370779 10915739 14550746 12705907 17562736 11834606 10663392 18713872 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 3.51 | 20420201 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 4.07 | 19426721 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.73 | 11462148 | |
MESH:D004487 | Edema | Cimetidine | 11.55 | 19703484 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 11.55 | 12711302 11000095 | |
MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 11.55 | 15177302 8113982 16716910 9599246 8273558 7812673 11698051 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 11.85 | 15322242 18230668 16714409 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 11.85 | 18230668 | |
MESH:D018159 | Endolymphatic Hydrops | Dimethyl Sulfoxide | 6.53 | 20641076 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 3.08 | 16569247 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.98 | 9294722 10568697 | |
MESH:D004938 | Esophageal Neoplasms | Zinc | 2.85 | 16543248 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 8.72 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 8.72 | 16938888 9664655 | |
MESH:D005234 | Fatty Liver | arsenite | 3.74 | 18296743 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.42 | 11858732 | |
MESH:D005355 | Fibrosis | arsenite | 14.62 | 18296743 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 14.62 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 14.62 | 17994277 | |
MESH:D005756 | Gastritis | Acetaminophen | 11.07 | 16983495 | |
MESH:D005756 | Gastritis | Zinc | 11.07 | 17241300 | |
MESH:D005909 | Glioblastoma | Tretinoin | 2.98 | 17312396 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.57 | 10696789 | |
MESH:D006130 | Growth Disorders | Zinc | 3.93 | 17217573 | |
MESH:D006258 | Head and Neck Neoplasms | N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine | 8.45 | 18986763 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 8.45 | 16096774 | |
MESH:D034381 | Hearing Loss | Dimethyl Sulfoxide | 5.13 | 20641076 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 5.13 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 6.46 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 6.46 | 9664655 14991402 | |
MESH:D006333 | Heart Failure | Zinc | 3.58 | 17162251 | |
MESH:D006335 | Heart Injuries | Zinc | 5.74 | 17074742 | |
MESH:D016481 | Helicobacter Infections | Zinc | 4.49 | 17241300 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.29 | 11000095 | |
MESH:D006527 | Hepatolenticular Degeneration | Zinc | 4.65 | 17276780 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.85 | 16120746 15340226 12621046 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 4.02 | 15340226 16354765 8697196 16959395 18606429 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 7.50 | 16870215 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 7.50 | 16870215 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.53 | 16778211 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 1.89 | 18850075 18670907 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 8.36 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 8.36 | 15177302 8273558 7562506 7812673 11698051 | |
MESH:D007249 | Inflammation | Tobacco Smoke Pollution | 8.36 | 18590791 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.73 | 17994277 | |
MESH:D007511 | Ischemia | Zinc | 4.59 | 16584753 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 9.80 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 9.80 | 15992940 17551590 | |
MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 5.60 | 16144296 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 6.07 | 15629191 12587719 | |
MESH:D007674 | Kidney Diseases | Zinc | 6.07 | 16960431 | |
MESH:D007676 | Kidney Failure, Chronic | Zinc | 4.38 | 16518626 | |
MESH:D007938 | Leukemia | Tretinoin | 2.75 | 17143497 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 3.66 | 16482212 19285840 16932348 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 4.46 | 16294345 19850784 17596541 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Vitamin D | 4.46 | 20368581 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | marker/mechanism | 16764927 | ||
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 3.12 | 19035177 17217047 17649720 19225113 19075265 16140955 16891316 17368321 17361223 17506722 17107899 19029980 16788101 12679006 16823087 16331271 17339181 15748426 17294898 16766008 19642359 16935935 17712046 17301526 9834237 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 3.27 | 9224671 | |
MESH:D008103 | Liver Cirrhosis | arsenite | 3.39 | 18296743 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethyl Sulfoxide | 3.62 | 11682029 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 3.62 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 3.62 | 18397230 16248980 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 1.62 | 19784758 16611625 11587558 16610002 19460945 12587719 19014921 12969438 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 3.20 | 16871587 17185352 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 1.70 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 2.08 | 12151625 | |
MESH:D008171 | Lung Diseases | Asbestos, Serpentine | 7.85 | 17200189 | |
MESH:D008171 | Lung Diseases | Ozone | 7.85 | 8266340 19066396 | |
MESH:D055370 | Lung Injury | Ozone | 3.81 | 20417186 | |
MESH:D008175 | Lung Neoplasms | alitretinoin | 10.65 | 16413115 | |
MESH:D008175 | Lung Neoplasms | arsenite | 10.65 | 16809336 | |
MESH:D008175 | Lung Neoplasms | Asbestos, Serpentine | 10.65 | 11198217 | |
MESH:D008175 | Lung Neoplasms | Ozone | 10.65 | 8597069 7614698 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 10.65 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 10.65 | 11807781 | |
MESH:D008175 | Lung Neoplasms | Tobacco Smoke Pollution | 10.65 | 11091918 3440675 16288123 12111688 | |
MESH:D008180 | Lupus Erythematosus, Systemic | marker/mechanism | |||
MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 6.41 | 8985016 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 6.41 | 12773700 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.77 | 17453147 | |
MESH:D008545 | Melanoma | Tretinoin | 1.94 | 16752155 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 3.53 | 19513568 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 4.39 | 16940565 | |
MESH:D008679 | Metaplasia | Ozone | 5.08 | 10496685 | |
MESH:D009062 | Mouth Neoplasms | Tobacco Smoke Pollution | 4.31 | 15006635 | |
MESH:D052016 | Mucositis | irinotecan | 4.97 | 17159606 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 3.05 | 17596541 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.98 | 12213967 | |
MESH:D009362 | Neoplasm Metastasis | irinotecan | 3.15 | 18259882 | |
MESH:D009369 | Neoplasms | alitretinoin | 5.32 | 16946489 | |
MESH:D009369 | Neoplasms | Tretinoin | 5.32 | 16946489 16594593 | |
MESH:D009374 | Neoplasms, Experimental | Asbestos, Serpentine | 4.81 | 11704859 | |
MESH:D009389 | Neovascularization, Pathologic | arsenite | 4.38 | 15738583 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 9.38 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 9.38 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 3.02 | 9142499 | |
MESH:D009447 | Neuroblastoma | irinotecan | 3.46 | 8761367 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 2.83 | 18514411 | |
MESH:D017599 | Neuroectodermal Tumors | irinotecan | 4.69 | 8761367 | |
MESH:D010024 | Osteoporosis | Vitamin D | 4.69 | 17882678 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 2.33 | 16936753 | |
MESH:D010146 | Pain | Acetaminophen | 6.46 | 16870215 | |
MESH:D010146 | Pain | Tretinoin | 6.46 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 5.46 | 15976015 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 5.46 | 15976015 | |
MESH:D010195 | Pancreatitis | Cimetidine | 5.24 | 10484002 | |
MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 4.25 | 12065085 18922899 18404319 8330346 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.22 | 12520081 | |
MESH:D010538 | Peritonitis | Ozone | 4.09 | 16369182 | |
MESH:D010995 | Pleural Diseases | Asbestos, Serpentine | 5.65 | 10923243 | |
MESH:D011014 | Pneumonia | Ozone | 4.36 | 18381685 18929643 18007984 | |
MESH:D017499 | Porokeratosis | alitretinoin | 5.98 | 16144296 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.52 | 18163543 | |
MESH:D011225 | Pre-Eclampsia | Zinc | 4.14 | 17114810 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 3.16 | 11896295 11118676 11222880 11399792 | |
MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 3.85 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Zinc | 3.85 | 16606632 16517595 16700911 12429649 | |
MESH:D011507 | Proteinuria | Tretinoin | 3.56 | 16636307 | |
MESH:D011625 | Pterygium | Tretinoin | 4.76 | 16723453 | |
MESH:D011658 | Pulmonary Fibrosis | Asbestos, Serpentine | 3.81 | 18569384 15511213 | |
MESH:D012135 | Respiratory Sounds | Tobacco Smoke Pollution | 4.58 | 18410779 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.80 | 18990726 | |
MESH:D012162 | Retinal Degeneration | Zinc | 4.09 | 16584753 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 4.06 | 16116481 16283617 | |
MESH:D012772 | Shock, Septic | Triprolidine | 6.18 | 18063050 | |
MESH:D012852 | Sinusitis | Triprolidine | 6.30 | 7327846 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 13.47 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 13.47 | 8330346 8985016 18404319 12065085 11807781 | |
MESH:D012878 | Skin Neoplasms | Tobacco Smoke Pollution | 13.47 | 18590791 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 13.47 | 16467112 | |
MESH:D013274 | Stomach Neoplasms | irinotecan | 2.63 | 15723263 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 2.63 | 17261132 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.87 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 2.99 | 16026305 17045167 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 9.85 | 16051514 | |
MESH:D014062 | Tongue Neoplasms | Zinc | 9.85 | 16543248 | |
MESH:D014376 | Tuberculosis | Tretinoin | 3.20 | 16040207 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tobacco Smoke Pollution | 3.32 | 12846360 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.94 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 3.64 | 16129372 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 4.58 | 16752155 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.57 | 12125929 | |
MESH:D014820 | Vitiligo | Tretinoin | 4.02 | 16761959 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.22 | 15886252 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.93 | 16287080 |
Pathway ID | Pathway Name |
---|---|
REACT:604 | Hemostasis |
REACT:13552 | Integrin cell surface interactions |
KEGG:04810 | Regulation of actin cytoskeleton |
KEGG:05152 | Tuberculosis |